This paper is in the following e-collection/theme issue:

mHealth for Treatment Adherence (404) Mobile Health (mhealth) (2982) Mobile Health in Psychiatry (438) Psychotic Disorders (162)

Published on in Vol 5, No 2 (2017): February

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Authors of this article:

Earle E Bain1 Author Orcid Image ;   Laura Shafner2 Author Orcid Image ;   David P Walling3 Author Orcid Image ;   Ahmed A Othman1 Author Orcid Image ;   Christy Chuang-Stein4 Author Orcid Image ;   John Hinkle5 Author Orcid Image ;   Adam Hanina2 Author Orcid Image
Article Authors Cited by (93) Tweetations (19) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.